DeutschNewstral
Article
Mmarketwatch.com on 2019-07-03 14:23
Unum Therapeutics stock plunges toward record low after FDA places 'clinical hold' on trial
Related news
Larimar Therapeutics stock plunges after FDA halts clinical trialbizjournals.com- MAgile Therapeutics plunges toward record low after FDA rejects contraceptive patch's NDAmarketwatch.com
- MRepros Therapeutics stock halted after FDA says partial clinical hold will continue for fibroids drugmarketwatch.com
- MCapricor Therapeutics stock rises 18% on FDA clearance for DMD clinical trialmarketwatch.com
- MMersana Therapeutics says FDA has lifted partial clinical hold on cancer therapy trialmarketwatch.com
- MPain Therapeutics stock plunges after company slams FDA for refusing to approve drugmarketwatch.com
- MCytori Therapeutics' stock plunges toward record low after stock offering prices at deep discountmarketwatch.com
- BUnum Therapeutics Dives After Cancer Drug Trial Suspendedbarrons.com
FDA Approves Sage Therapeutics’ Zulressowsj.com
FDA OKs United Therapeutics’ cancer drugthedailyrecord.com- United Therapeutics scores another FDA approvalbizjournals.com
- FDA lifts suspension of Juno clinical trialbizjournals.com
Rani Therapeutics’ $73M IPO will fund upcoming clinical trialsTechCrunch- FDA clears ALung device for clinical trialsbizjournals.com
FDA approves new Baxter clinical nutrition injectionsdailyherald.com- Amid FDA hold, Unum says chief medical officer will stay involved for 2 yearsbizjournals.com
- MSarepta Therapeutics shares dive on safety issues in FDA databasemarketwatch.com
- FDA advisory panel recommends approval of Spark Therapeutics' gene therapybizjournals.com
- MPTC Therapeutics gains after FDA panel votes against drug approvalmarketwatch.com